Small Cell Carcinoma of Ovary, Hypercalcemic Type: A Rare Case Report


Coşkun Ç., KURUCU N., USUBÜTÜN A., SOYER T., ÖZCAN H. N., Çelik Ertaş N. B., ...Daha Fazla

Journal of Pediatric and Adolescent Gynecology, cilt.36, sa.2, ss.112-115, 2023 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 36 Sayı: 2
  • Basım Tarihi: 2023
  • Doi Numarası: 10.1016/j.jpag.2022.10.004
  • Dergi Adı: Journal of Pediatric and Adolescent Gynecology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.112-115
  • Anahtar Kelimeler: Biomarkers, Hypercalcemia in malignancy, Ovarian neoplasm, Small cell carcinoma of ovary
  • Hacettepe Üniversitesi Adresli: Evet

Özet

© 2022Background: Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT), is a rare neoplasm that occurs mostly in women younger than 40 years of age. The unknown histogenesis makes the diagnosis of SCCOHT difficult. SCCOHT was recently shown to be associated with SMARCA4 gene mutation. Serum calcium levels can be used as a marker of treatment response and relapse in SCCOHT. Case Report: Here we report on a 16-year-old girl who presented with pelvic mass and hypercalcemia. SCCOHT was diagnosed histopathologically. However, loss of neither BRG1 nor INI1 expression was detected. Summary and Conclusion: The diagnosis of SCCOHT should be among the differential diagnoses in adolescents presenting with pelvic mass and hypercalcemia. We would like to share our experience with this rare case, discuss recent management, and emphasize the importance of a multidisciplinary approach. Although it is known that almost all cases have a loss of BRG1 expression and a small group exhibit loss of INI1, our patient indicates that there could be exceptional cases with hitherto undescribed genetic abnormalities.